ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 146 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,850 | +2.8% | 89,700 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,800 | +25.3% | 89,700 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,436 | -16.7% | 89,700 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $1,723 | -99.9% | 89,700 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $1,236,000 | -35.5% | 89,700 | -40.3% | 0.00% | -33.3% |
| Q2 2022 | $1,915,000 | -20.1% | 150,200 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $2,396,000 | -18.5% | 150,200 | +14.2% | 0.01% | -14.3% |
| Q4 2021 | $2,939,000 | -23.4% | 131,500 | +1.7% | 0.01% | -36.4% |
| Q3 2021 | $3,836,000 | -30.5% | 129,300 | 0.0% | 0.01% | -31.2% |
| Q2 2021 | $5,521,000 | +137.7% | 129,300 | +138.1% | 0.02% | +100.0% |
| Q1 2021 | $2,323,000 | -10.9% | 54,300 | +14.8% | 0.01% | -20.0% |
| Q4 2020 | $2,607,000 | +55.5% | 47,300 | -35.8% | 0.01% | +42.9% |
| Q3 2020 | $1,677,000 | – | 73,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |